Biocryst Pharmaceuticals (BCRX) Shares Outstanding (Diluted) (2013 - 2026)
Biocryst Pharmaceuticals (BCRX) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 833.33 Mn |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 265.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 265.17 Mn |
| Mar 31, 2026 | 242.26 Mn |
| Dec 31, 2025 | 218.58 Mn |
| Sep 30, 2025 | 219.89 Mn |
| Jun 30, 2025 | 219.89 Mn |
| Mar 31, 2025 | 215.26 Mn |
| Dec 31, 2024 | 206.70 Mn |
| Sep 30, 2024 | 206.91 Mn |
| Jun 30, 2024 | 206.43 Mn |
| Mar 31, 2024 | 206.06 Mn |
| Dec 31, 2023 | 192.20 Mn |
| Sep 30, 2023 | 189.64 Mn |
| Jun 30, 2023 | 189.12 Mn |
| Mar 31, 2023 | 188.51 Mn |
| Dec 31, 2022 | 185.91 Mn |
| Sep 30, 2022 | 186.18 Mn |
| Jun 30, 2022 | 185.61 Mn |
| Mar 31, 2022 | 184.90 Mn |
| Dec 31, 2021 | 179.12 Mn |
| Sep 30, 2021 | 179,106.00 |